FGC
IBIO icon

Financial Gravity Companies’s iBio IBIO Stock Holding History

Financial Gravity Companies’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$2 Buy
+2
New +$2 ﹤0.01% 984
2024
Q4 		$5 Hold
2
– – ﹤0.01% 961
2024
Q3 		$4 Buy
+2
New +$4 ﹤0.01% 668

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Gravity Companies's IBIO Position: Q2 2025 in Review

Financial Gravity Companies opened a new position in iBio (IBIO) in Q2 2025: 2 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #984 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in IBIO as recently as Q4 2024.

Financial Gravity Companies first reported a position in IBIO in Q3 2024 and has held it in 3 quarters since. The position peaked at $5 in Q4 2024. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

  • Financial Gravity Companies held 2 shares of iBio worth $2 as of Q2 2025.
  • iBio was a new Financial Gravity Companies position in Q2 2025.
  • iBio made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2025, its #984 holding.
  • Financial Gravity Companies first reported a position in iBio in Q3 2024 and has held it in 3 quarters since.
  • Financial Gravity Companies's iBio position peaked at $5 in Q4 2024.
  • 30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Financial Gravity Companies's 13F filing for Q2 2025, filed 8 Aug 2025.